Tzu-Hua Chen-Liang

Dr. Tzu-Hua Chen-Liang

Servicio de Hematología y Oncología Médica. Hospital General Universitario Morales Meseguer. Murcia.
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2015 in American Journal of Hematology
Verified
Journal Article
Open access
PDF file
TCTzu-Hua Chen-Liang
Tzu-Hua Chen-Liang
TMTaida Martin‐Santos
Taida Martin‐Santos
AJAndres Jerez
Andres Jerez
LSLeonor Senent
Leonor Senent
MOMaria Teresa Orero
Maria Teresa Orero
FOFrancisco Jose Ortuño
Francisco Jose Ortuño
Bone marrow infiltration (BMI), categorized as an extra‐nodal site, affects stage and is associated with poor prognosis in newly diagnosed lymphoma patients. We have evaluated the accuracy of PET/CT and bone marrow biopsy (BMB) to assess BMI in 372 lymphoma patients [140 Hodgkin Lymphoma (HL) and 232 High Grade B‐cell non‐Hodgkin Lymphoma (HG B‐NHL), among them 155 Diffuse Large B‐Cell Lymphoma (DLCL)]. For HL cases, and taking into account PET/CT, sensitivity, negative predictive value (NPV) and accuracy were 96.7, 99.3, and 99.3% while those of BMB were 32.3, 83.8, and 85%, respectively. For HG B‐NHL and considering PET/CT, sensitivity, NPV, and accuracy were 52.7, 81.7, and 84.1%, while those of BMB were 77.6, 90.2, and 90.7%, respectively. In the HG B‐NHL group, 25 patients would have been under‐staged without BMB. These results lead us to recommend PET/CT and the avoidance of BMB to assess BMI in HL. In the case of HG B‐NHL, bone marrow status should be assessed firstly by means of PET/CT; only in either focal or diffuse PET/CT with low borderline SUV max values or in negative cases, should BMB be carried out afterwards. In the HG B‐NHL setting and at the present moment, both techniques are complementary. Am. J. Hematol. 90:686–690, 2015.

7 May 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
DKDaehong Kim
Daehong Kim
GPGiljun Park
Giljun Park
JHJani Huuhtanen
Jani Huuhtanen
SLSofie Lundgren
Sofie Lundgren
RKRajiv K. Khajuria
Rajiv K. Khajuria
SMSatu Mustjoki
Satu Mustjoki
Graft versus host disease (GvHD) is the main complication of allogeneic hematopoietic stem cell transplantation (HSCT). Here we report studies of a patient with chronic GvHD (cGvHD) carrying persistent CD4+ T cell clonal expansion harboring somatic mTOR, NFKB2, and TLR2 mutations. In the screening cohort (n = 134), we detect the mTOR P2229R kinase domain mutation in two additional cGvHD patients, but not in healthy or HSCT patients without cGvHD. Functional analyses of the mTOR mutation indicate a gain-of-function alteration and activation of both mTORC1 and mTORC2 signaling pathways, leading to increased cell proliferation and decreased apoptosis. Single-cell RNA sequencing and real-time impedance measurements support increased cytotoxicity of mutated CD4+ T cells. High throughput drug-sensitivity testing suggests that mutations induce resistance to mTOR inhibitors, but increase sensitivity for HSP90 inhibitors. Our findings imply that somatic mutations may contribute to aberrant T cell proliferations and persistent immune activation in cGvHD, thereby paving the way for targeted therapies.

5 January 2016 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
JMJulia Muñoz‐Ballester
Julia Muñoz‐Ballester
TCTzu-Hua Chen-Liang
Tzu-Hua Chen-Liang
ALAna María Hurtado López
Ana María Hurtado López
IHInmaculada Heras
Inmaculada Heras
FAFelipe de Arriba
Felipe de Arriba
AJAndrés Jérez
Andrés Jérez

13 November 2018 in European Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
MFMariana Fernández‐Caballero
Mariana Fernández‐Caballero
DSDiego Salmerón
Diego Salmerón
MCMaría Dolores Chirlaque
María Dolores Chirlaque
TCTzu-Hua Chen-Liang
Tzu-Hua Chen-Liang
ALAna María Hurtado López
Ana María Hurtado López
FAFelipe De Arriba
Felipe De Arriba

17 May 2022 in Blood Cancer Journal
Verified
Journal Article
Open access
PDF file
PGPaloma García-Martín
Paloma García-Martín
ADAna Moñiz Díez
Ana Moñiz Díez
JMJosé Manuel Sánchez Maldonado
José Manuel Sánchez Maldonado
ASAntonio José Cabrera Serrano
Antonio José Cabrera Serrano
RHRob ter Horst
Rob ter Horst
Juan SainzJuan Sainz
Juan Sainz

27 September 2018 in Transfusion
Verified
Journal Article
Closed access
PDF file
PIPastora Iniesta
Pastora Iniesta
NRNuria Revilla
Nuria Revilla
TCTzu-Hua Chen-Liang
Tzu-Hua Chen-Liang
ALAna María Hurtado López
Ana María Hurtado López
VVVicente Vicente
Vicente Vicente
MLMaria L Lozano
Maria L Lozano